EQS Newswire

eqs August 1, 2022

EQS 新闻 via SEAPRWire.com / 2022-08-01 / 05:21 EST/EDT 拜登计划两年内将迷幻药疗法合法化   经过十多年被误解后,迷幻药疗法终于在医学上取得认可,美国卫生和公共服务部的信件披露了美国食品和…

admin July 5, 2022

EQS-News / 04/07/2022 / 17:56 UTC+8 CICC Initiates Sirnaomics (2257.HK) at Outperform Rating with Target Price of HKD106.00   China International Capital Corporation (CICC) initiates coverage of Sirnaomics at “Outperform” rating, with a target price of HKD106.00. CICC said, Sirnaomics is an RNA therapeutics pioneer in China. RNA therapeutics is a rapidly growing field with potential […]